SAN DIEGO--(BUSINESS WIRE)--The Mentor Capital, Inc. (OTCQB: MNTR) team will be answering investor questions on the going public process at the G FarmaLabs booth at the NCIA Cannabis Business Summit and Expo June 12 – 14 in Oakland, CA. “Working side-by-side with G Farma at the show or as we fund their business expansion is both personally and professionally rewarding,” says Mentor CEO Chet Billingsley. “Under the talented business guidance of G FarmaLabs founder, Ata Gonzalez, who recently pulled down a third 2017 Mentor funding tranche, the G Farma team continues to expand the almost 100 cannabis infused products they distribute across more than 1,100 dispensaries.”
Commenting on the overall Mentor funding process, Ata Gonzalez adds, “Our partnership contract was clear, professional and fair. We are now one step closer to our goal of becoming a publicly traded company.”
This marries well with Mentor Capital’s business goal. “We look to work with the larger cannabis companies and provide bridge funding, founder liquidity and regulatory guidance as we mentor them through the process of moving from a wholly private company into the often more highly valued public arena,” explains Billingsley.
About Mentor Capital: The Company seeks to come alongside and assist private medical marijuana and cannabis companies and their founders in meeting their liquidity and financial objectives, to add protection for investors and to help incubate private cannabis companies. Additional important information for investors is presented at: www.MentorCapital.com .
This press release is neither an offer to sell, nor a solicitation of offers to purchase, securities.
Forward Looking Statements: This press release contains forward-looking statements within the meaning of the federal securities laws, including statements concerning financial projections, financing activities, corporate combinations, product development activities and sales and licensing activities. Such forward-looking statements are not guarantees of future results or performance, are sometimes identified by words of condition such as “should,” “could,” “expects,” “may,” “intends,” “seeks,” “looks,” “moves,” or “plans” and are subject to a number of risks and uncertainties, known and unknown, that could cause actual results to differ materially from those intended or anticipated. Such risks include, without limitation: nonperformance of investments, partner and portfolio difficulties, potential delays in marketing and sales, problems securing the necessary financing to continue operations, problems involving continued illegality of cannabis products, potential of competitive products, services, and technologies, difficulties experienced in product development, in recruiting knowledgeable personnel, in collecting judgments and in protecting intellectual property. Further information concerning these and other risks is included in the Company’s Form 10-K and 10-Q filings which, along with other very important information about the Company, can be found here:
The Company undertakes no obligation to update or revise such forward-looking statements to reflect new information, events or circumstances occurring after the date of this press release.